• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 COVID-19 严重程度相关的社会人口学决定因素和临床危险因素:对伊朗德黑兰 20 多万患者的横断面分析。

Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran.

机构信息

Community Medicine Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

BMC Infect Dis. 2021 May 25;21(1):474. doi: 10.1186/s12879-021-06179-4.

DOI:10.1186/s12879-021-06179-4
PMID:34034649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8146170/
Abstract

BACKGROUND

Defining socio-demographic factors, clinical presentations and underlying diseases associated with COVID-19 severity could be helpful in its management. This study aimed to further clarify the determinants and clinical risk factors of the disease severity in patients infected with COVID-19.

METHODS

A multi-centre descriptive study on all patients who have been diagnosed with COVID-19 in the province of Tehran from March 2020 up to Dec 2020 was conducted. Data on socio-demographic characteristics, clinical presentations, comorbidities, and the health outcomes of 205,654 patients were examined. Characteristics of the study population were described. To assess the association of study variables with the disease severity, the Chi-Squared test and Multiple Logistic Regression model were applied.

RESULTS

The mean age of the study population was 52.8 years and 93,612 (45.5%) were women. About half of the patients have presented with low levels of blood oxygen saturation. The ICU admission rate was 17.8% and the overall mortality rate was 10.0%. Older age, male sex, comorbidities including hypertension, cancer, chronic respiratory diseases other than asthma, chronic liver diseases, chronic kidney diseases, chronic neurological disorders, and HIV/AIDS infection were risk markers of poor health outcome. Clinical presentations related with worse prognosis included fever, difficulty breathing, impaired consciousness, and cutaneous manifestations.

CONCLUSION

These results might alert physicians to pay attention to determinants and risk factors associated with poor prognosis in patients with COVID-19. In addition, our findings aid decision makers to emphasise on vulnerable groups in the public health strategies that aim at preventing the spread of the disease and its mortalities.

摘要

背景

明确与 COVID-19 严重程度相关的社会人口学因素、临床表现和基础疾病有助于对其进行管理。本研究旨在进一步阐明 COVID-19 感染患者疾病严重程度的决定因素和临床危险因素。

方法

对 2020 年 3 月至 2020 年 12 月在德黑兰省诊断为 COVID-19 的所有患者进行了一项多中心描述性研究。检查了 205654 例患者的社会人口学特征、临床表现、合并症和健康结果数据。描述了研究人群的特征。为了评估研究变量与疾病严重程度的关联,应用了卡方检验和多因素逻辑回归模型。

结果

研究人群的平均年龄为 52.8 岁,其中 93612 人(45.5%)为女性。约一半的患者血氧饱和度水平较低。入住 ICU 的比例为 17.8%,总死亡率为 10.0%。年龄较大、男性、合并症包括高血压、癌症、除哮喘以外的慢性呼吸系统疾病、慢性肝病、慢性肾脏病、慢性神经疾病和 HIV/AIDS 感染是不良健康结局的风险标志物。与预后不良相关的临床表现包括发热、呼吸困难、意识障碍和皮肤表现。

结论

这些结果可能会提醒医生注意与 COVID-19 预后不良相关的决定因素和危险因素。此外,我们的研究结果还帮助决策者在旨在预防疾病传播和死亡率的公共卫生策略中强调弱势群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/8152138/b364505d0544/12879_2021_6179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/8152138/cbb1290adcc8/12879_2021_6179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/8152138/b364505d0544/12879_2021_6179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/8152138/cbb1290adcc8/12879_2021_6179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/8152138/b364505d0544/12879_2021_6179_Fig2_HTML.jpg

相似文献

1
Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran.与 COVID-19 严重程度相关的社会人口学决定因素和临床危险因素:对伊朗德黑兰 20 多万患者的横断面分析。
BMC Infect Dis. 2021 May 25;21(1):474. doi: 10.1186/s12879-021-06179-4.
2
Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.在加拿大,167500 例 COVID-19 患者中,先前存在的合并症与死亡率和疾病严重程度的关系:一项基于人群的队列研究。
PLoS One. 2021 Oct 5;16(10):e0258154. doi: 10.1371/journal.pone.0258154. eCollection 2021.
3
COVID-19 in pregnancy: A cross-sectional study on clinical features, disease severity, and health outcome.妊娠期 COVID-19:一项关于临床特征、疾病严重程度和健康结局的横断面研究。
Biomol Biomed. 2024 May 2;24(3):659-664. doi: 10.17305/bb.2023.9748.
4
Risk factors associated with worse outcomes in COVID-19: a retrospective study in Saudi Arabia.与 COVID-19 预后较差相关的风险因素:沙特阿拉伯的一项回顾性研究。
East Mediterr Health J. 2020 Nov 11;26(11):1371-1380. doi: 10.26719/emhj.20.130.
5
Urban and sub-urban disparities in health outcomes among patients with COVID-19; a cross-sectional study of 234 418 patients in Iran.城市和城乡 COVID-19 患者健康结局的差异;对伊朗 234418 名患者的横断面研究。
BMC Public Health. 2022 May 10;22(1):927. doi: 10.1186/s12889-022-13290-x.
6
Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.伊朗马什哈德医科大学的一项横断面研究:严重 COVID-19 感染的人口统计学和临床特征。
BMC Infect Dis. 2021 Jul 7;21(1):656. doi: 10.1186/s12879-021-06363-6.
7
Demographics, comorbidities and risk factors for severe disease from the early SARS-CoV-2 infection cases in Queensland, Australia.澳大利亚昆士兰州早期 SARS-CoV-2 感染病例的人口统计学、合并症和重症疾病风险因素。
Intern Med J. 2024 May;54(5):786-794. doi: 10.1111/imj.16276. Epub 2023 Nov 13.
8
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
9
Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave.孟加拉国第二波疫情期间 COVID-19 患者合并症的流行率及其对疾病预后的影响:一项全国性研究。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102148. doi: 10.1016/j.dsx.2021.05.021. Epub 2021 Jun 27.
10
Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020.2020 年大邱市新冠肺炎暴发期间的新冠肺炎患者临床特征和结局。
J Korean Med Sci. 2021 Jan 4;36(1):e12. doi: 10.3346/jkms.2021.36.e12.

引用本文的文献

1
Health risk assessment for severe COVID-19 in Taiwan: a multi-centre electronic health record study.台湾地区重症新型冠状病毒肺炎的健康风险评估:一项多中心电子健康记录研究
J Glob Health. 2025 Sep 5;15:04236. doi: 10.7189/jogh.15.04236.
2
Characteristic Symptoms and Associated Risk Factors of COVID-19 Reinfection in the Indonesian Community.印度尼西亚社区新冠病毒再次感染的特征性症状及相关风险因素
Yonago Acta Med. 2025 Aug 8;68(3):209-219. doi: 10.33160/yam.2025.08.005. eCollection 2025 Aug.
3
Role of Galanin system and insulin resistance parameters as predictive tools for diagnosis of Long-COVID patients.

本文引用的文献

1
Clinical features and short-term outcomes of patients with COVID-19 due to different exposure history.不同暴露史的新型冠状病毒肺炎患者的临床特征及短期预后
Medicine (Baltimore). 2020 Nov 20;99(47):e23319. doi: 10.1097/MD.0000000000023319.
2
Baseline Characteristics and Associated Factors of Mortality in COVID-19 Patients; an Analysis of 16000 Cases in Tehran, Iran.新冠病毒肺炎患者死亡率的基线特征及相关因素:伊朗德黑兰16000例病例分析
Arch Acad Emerg Med. 2020 Sep 6;8(1):e70. eCollection 2020.
3
Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients.
甘丙肽系统和胰岛素抵抗参数作为预测工具在长新冠患者诊断中的作用。
Biochem Biophys Rep. 2025 Jun 3;43:102068. doi: 10.1016/j.bbrep.2025.102068. eCollection 2025 Sep.
4
COVID-19 severity and vaccine effectiveness in Malawi: A test-negative case-control study.马拉维的新冠病毒疾病严重程度及疫苗效力:一项检测呈阴性的病例对照研究。
J Public Health Afr. 2025 Apr 11;16(1):758. doi: 10.4102/jphia.v16i1.758. eCollection 2025.
5
Clinical manifestations and treatment outcomes among hospitalised COVID-19 patients in tertiary hospitals in Tanzania, 2021-2022: a retrospective cohort study.2021 - 2022年坦桑尼亚三级医院住院COVID - 19患者的临床表现及治疗结果:一项回顾性队列研究
BMJ Public Health. 2024 Aug 16;2(2):e000881. doi: 10.1136/bmjph-2023-000881. eCollection 2024 Dec.
6
Joint modeling of longitudinal and competing risks for assessing blood oxygen saturation and its association with survival outcomes in COVID-19 patients.用于评估新冠肺炎患者血氧饱和度及其与生存结局关联的纵向和竞争风险联合建模
J Educ Health Promot. 2024 Mar 28;13:91. doi: 10.4103/jehp.jehp_246_23. eCollection 2024.
7
Modeling risk factors of degree of severity of Coronavirus disease 2019 (COVID-19) infection in inpatient patients at Dr. M. Djamil Padang.对巴东M. 贾米尔博士医院住院的2019冠状病毒病(COVID-19)感染患者的严重程度风险因素进行建模。
J Public Health Res. 2023 Nov 18;12(4):22799036231204341. doi: 10.1177/22799036231204341. eCollection 2023 Oct.
8
Polymerase chain reaction-positivity and predictors for SARS-CoV-2 infection among diagnosed cases' in North West Ethiopia.埃塞俄比亚西北部确诊病例中新冠病毒聚合酶链反应阳性情况及感染预测因素
Health Sci Rep. 2023 Oct 26;6(10):e1663. doi: 10.1002/hsr2.1663. eCollection 2023 Oct.
9
Leukopenia and leukocytosis as strong predictors of COVID-19 severity: A cross-sectional study of the hematologic abnormalities and COVID-19 severity in hospitalized patients.白细胞减少和白细胞增多作为新冠病毒疾病严重程度的有力预测指标:一项关于住院患者血液学异常与新冠病毒疾病严重程度的横断面研究
Health Sci Rep. 2023 Sep 27;6(10):e1574. doi: 10.1002/hsr2.1574. eCollection 2023 Oct.
10
Electrolyte Imbalance Among Bangladeshi Patients With COVID-19.孟加拉国新冠肺炎患者的电解质失衡
Cureus. 2023 Feb 23;15(2):e35352. doi: 10.7759/cureus.35352. eCollection 2023 Feb.
新型冠状病毒肺炎(COVID-19)预后与住院患者疾病表现、合并症和慢性治疗的关系。
PLoS One. 2020 Oct 15;15(10):e0239571. doi: 10.1371/journal.pone.0239571. eCollection 2020.
4
Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort.大型美国队列研究中 COVID-19 患者院内死亡的早期预测因素。
Intern Emerg Med. 2020 Nov;15(8):1485-1499. doi: 10.1007/s11739-020-02509-7. Epub 2020 Sep 24.
5
Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women?冠状病毒:为何男性比女性更容易感染新冠病毒?
SN Compr Clin Med. 2020;2(7):874-876. doi: 10.1007/s42399-020-00341-w. Epub 2020 Jun 4.
6
Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes.COVID-19 流行病学:临床特征、危险因素和结局的系统评价和荟萃分析。
J Med Virol. 2021 Mar;93(3):1449-1458. doi: 10.1002/jmv.26424. Epub 2020 Aug 25.
7
Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait.科威特首批连续确诊的1096例新冠肺炎患者的特征、风险因素及预后
EClinicalMedicine. 2020 Jul 4;24:100448. doi: 10.1016/j.eclinm.2020.100448. eCollection 2020 Jul.
8
Social Determinants of COVID-19 in Massachusetts, United States: An Ecological Study.美国马萨诸塞州新冠病毒病的社会决定因素:一项生态学研究
J Prev Med Public Health. 2020 Jul;53(4):220-227. doi: 10.3961/jpmph.20.256. Epub 2020 Jun 24.
9
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study.10021 例新冠肺炎住院患者的病例特征、资源利用和结局:一项观察性研究。
Lancet Respir Med. 2020 Sep;8(9):853-862. doi: 10.1016/S2213-2600(20)30316-7. Epub 2020 Jul 28.
10
Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis.COVID-19患者合并症的患病率:一项系统评价和荟萃分析。
Arch Bone Jt Surg. 2020 Apr;8(Suppl 1):247-255. doi: 10.22038/abjs.2020.47754.2346.